SJS Investment Consulting’s Damora Therapeutics DMRA Stock Holding History

SJS Investment Consulting’s Portfolio DMRA Stock Details DMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$213	Buy	+10	New	+$283	﹤0.01%	2930

Other funds holding DMRA

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Parkside Financial Bank & Trust Saint Louis, Missouri $1.51B AUM 17.86% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

SJS Investment Consulting's DMRA Position: Q3 2026 in Review

SJS Investment Consulting opened a new position in Damora Therapeutics (DMRA) in Q3 2026: 10 shares worth $213. The stake represents ﹤0.01% of the portfolio and ranks #2930 among its holdings.

10 funds tracked by Wall St. Rank hold DMRA as of Q3 2026.

SJS Investment Consulting held 10 shares of Damora Therapeutics worth $213 as of Q3 2026.
Damora Therapeutics was a new SJS Investment Consulting position in Q3 2026.
Damora Therapeutics made up ﹤0.01% of SJS Investment Consulting's portfolio in Q3 2026, its #2930 holding.
10 funds tracked by Wall St. Rank held Damora Therapeutics as of Q3 2026.

Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.